New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 13, 2012
11:49 EDTQCORQuestcor down 6% following presentation at investor conference
Shares of biopharmaceutical company Questcor Pharmaceuticals (QCOR) slid in mid-morning trading as the company presented at the JMP Securities Healthcare Conference. During the presentation, the company's Chief Scientific Officer discussed the mechanism of action and unique biological and clinical properties of the company's primary product, Acthar Gel. The company also focused on its strategic plan to focus on "the embedded pipeline in Acthar," highlighting its research and development plans. Investors may have been disappointed that the company did not directly speak to allegations recently made by short sellers, specifically the accusations made by Citron Research in a report published July 10. In mid-morning trading, Questcor fell $2.88, or 6.33%, to $42.60 after being up marginally at the open.
News For QCOR From The Last 14 Days
Check below for free stories on QCOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 15, 2014
06:08 EDTQCORQuestcor implied volatility of 28 at lower end of index mean range
Subscribe for More Information
August 14, 2014
17:21 EDTQCORGulfMark Offshore to replace Questcor in S&P 600 as of 8/18 close
17:16 EDTQCORPaulson & Co gives quarterly update on stakes
Subscribe for More Information
16:35 EDTQCORMallinckrodt completes acquisition of Questcor Pharmaceuticals
Subscribe for More Information
13:02 EDTQCORMallinckrodt, Questcor holders approve Mallinckrodt's acquisition of Questcor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use